Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) main shareholder Hengqin Dingdian and its concerted action party have completed the reduction of 757,400 shares.
West Point Pharmaceutical Co., Ltd. (301130.SZ) announced that its shareholder, Hengqin Dingdian Equity Investment Fund Partnership, holds more than 5% of the company's shares.
Announcement of Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Shareholders holding more than 5% of the company, Hengqin Dingdian Equity Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Hengqin Dingdian") and its concerted action person Zhuhai Hengqin Runhuiyi Investment Partnership Enterprise (Limited Partnership) (formerly known as Hengqin Runhuiyi Equity Investment Fund Partnership Enterprise (Limited Partnership)) (referred to as "Zhuhai Hengqin Runhuiyi"), have collectively reduced their shares by 757,400 shares, accounting for 0.99% of the total share capital. The implementation of this reduction plan has been completed.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
